Physician

Christopher Blake Myers, M.D.

According to 2025 Medicare claims, Christopher Myers, M.D. (NPI: 1023088770) practices ophthalmology in the Redding, CA market, with the plurality of this provider's patient population coming from Shasta, CA. This provider's primary affiliated billing organization is SHASTA EYE MEDICAL GROUP INC (NPI: 1346235603; TIN: 205756962) and primary practice location at 96002-2122.

Myers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,467 traditional Medicare patients, billed 22,375 HCPCS/CPT codes, and received $1,772,243 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,028 prescription claims across 457 beneficiaries totaling $234,307 in drug costs, led by Lumigan (Bimatoprost). 2021 DME data shows 22 claims. Open Payments data shows 17 records totaling $636. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $291,913 to $1,772,243. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $170,790 and ending at $234,307. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,723	3,391	$291,913
2016	1,731	3,476	$303,215
2017	1,770	3,311	$283,816
2018	2,145	4,233	$358,022
2019	2,010	3,952	$386,038
2020	2,007	3,686	$285,361
2021	1,203	5,743	$238,800
2022	1,328	5,798	$501,762
2023	1,803	17,873	$1,706,713
2024	1,467	22,375	$1,772,243

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	429	1,943	$170,790
2016	451	2,055	$219,256
2017	418	1,908	$233,249
2018	559	2,057	$287,014
2019	544	1,906	$432,888
2020	530	1,766	$322,713
2021	408	995	$132,818
2022	307	771	$99,364
2023	446	1,425	$223,363
2024	457	2,028	$234,307

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	120	120	$6,806
2016	156	166	$8,928
2017	105	105	$5,577
2018	74	74	$3,834
2019	86	86	$4,868
2020	64	64	$3,601
2021	11	22	$1,370
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	838	952	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	318	398	$69
92012	Established patient problem focused exam of visual system	523	773	$64
92134	Imaging of retina	546	1,698	$33
92250	Photography of the retina	336	438	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	106	6,717	$57,785
Restasis	Cyclosporine	28	1,665	$34,925
Cyclosporine	Cyclosporine	61	3,450	$26,612
Combigan	Brimonidine Tartrate/Timolol	42	2,169	$18,256
Rocklatan	Netarsudil Mesylat/Latanoprost	41	1,219	$16,281

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$636	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Blake Myers, M.D.?

Tedicare shows public-source Medicare data for Christopher Blake Myers, M.D. (NPI 1023088770), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Blake Myers, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Blake Myers, M.D.?

Christopher Blake Myers, M.D. is linked to SHASTA EYE MEDICAL GROUP INC (billing NPI 1346235603) in the available physician profile data.

Does Christopher Blake Myers, M.D. have Open Payments data?

Christopher Blake Myers, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.